An active metabolite of lidocaine
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MEGX (hydrochloride)

Item No. 28019

Technical Information
Formal Name
N-(2,6-dimethylphenyl)-2-(ethylamino)-acetamide, monohydrochloride
CAS Number
7729-94-4
Synonyms
  • Monoethylglycinexylidide
  • Norlidocaine
Molecular Formula
C12H18N2O • HCl
Formula Weight
Purity
≥95%
A solid
DMF: 1 mg/mlDMSO: 5 mg/mlEthanol: 2 mg/mlPBS (pH 7.2): 5 mg/ml
SMILES
CC1=CC=CC(C)=C1NC(CNCC)=O.Cl
InChi Code
InChI=1S/C12H18N2O.ClH/c1-4-13-8-11(15)14-12-9(2)6-5-7-10(12)3;/h5-7,13H,4,8H2,1-3H3,(H,14,15);1H
InChi Key
KPXFVVHMUVBVGI-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    MEGX is an active metabolite of lidocaine.1 It is formed via N-deethylation of lidocaine by the hepatic cytochrome P450 (CYP) isoform CYP3A4. Topical administration of MEGX (2% v/v) reduces thrombus formation in a hamster model of laser-induced microvascular injury.2 Plasma levels of MEGX following lidocaine administration have been used to monitor declining liver function in patients with cirrhosis.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Reichel, C., Skodra, T., Nacke, A., et alThe lignocaine metabolite (MEGX) liver function test and P-450 induction in humans. Br. J. Clin. Pharmacol. 46(6), 535-539 (1998).

    2. Luostarinen, V., Evers, H., Lyytikäinen, M.T., et alAntithrombotic effects of lidocaine and related compounds on laser-induced microvascular injury. Acta Anaesthesiol. Scand. 25(1), 9-11 (1981).